BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research TeamInvestigating Accelerated Deep TMS for Treatment of Alcohol Use D false

בריינסוויי בע"מ	2 380
BRAINSWAY LTD
Corporation no: 513890764	10767

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	03/11/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-083044	Time of broadcast: 10:46 10:46

The corporation scheduled the publication of the report to 04/11/2025 15:00

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

BrainsWay_Reports_NIH_Grant_Alcohol_Study_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: BWAY	Date of revision of form structure: 06/08/2024
Address: הרטום 19 , ירושלים 91451   , Tel: 02-5813140 , Fax: 02-5812517
E-mail address: uri@Brainsway.com   Company site: www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: hadarl@brainsway.com 1